| 1 | were | 863,432 |
| 2 | -were | 39 |
| 3 | -was | 9 |
| 4 | wee | 8 |
| 5 | wer | 8 |
| 6 | .zdv | 4 |
| 7 | -mean | 3 |
| 8 | -when | 3 |
| 9 | zr-hopo | 3 |
| 10 | .were | 2 |
| 11 | exenatide-failures | 2 |
| 12 | models-the | 2 |
| 13 | werde | 2 |
| 14 | -0123/rtog | 1 |
| 15 | -3-oxopropanal | 1 |
| 16 | -conformed | 1 |
| 17 | -f264y | 1 |
| 18 | -half | 1 |
| 19 | -hexa-2-en-4-ynoates | 1 |
| 20 | -hexapeptides | 1 |
| 21 | -kqlr-amc | 1 |
| 22 | -yield | 1 |
| 23 | .anova | 1 |
| 24 | .valued | 1 |
| 25 | /telmisartan | 1 |
| 26 | 9343 | 1 |
| 27 | anthracycline-cyclophosphamide | 1 |
| 28 | bacteremia.we | 1 |
| 29 | bodyweight-cut-point | 1 |
| 30 | c*3 | 1 |
| 31 | ce.6/26062/22061 | 1 |
| 32 | died/were | 1 |
| 33 | events.four | 1 |
| 34 | fatigue/vigor | 1 |
| 35 | fpsa.we | 1 |
| 36 | freelight-2 | 1 |
| 37 | g300104 | 1 |
| 38 | hypnotically | 1 |
| 39 | image-galleries | 1 |
| 40 | inattentiveness-were | 1 |
| 41 | leakage- | 1 |
| 42 | maternalcomplicationswere | 1 |
| 43 | mg/dl-was | 1 |
| 44 | mm6 | 1 |
| 45 | nscaw-1 | 1 |
| 46 | open-was | 1 |
| 47 | participants.screening | 1 |
| 48 | potencially | 1 |
| 49 | pweight-bearing*8685not | 1 |
| 50 | ratner | 1 |
| 51 | revalor-is | 1 |
| 52 | ring-slippage | 1 |
| 53 | se-i | 1 |
| 54 | severity-was | 1 |
| 55 | shengwei | 1 |
| 56 | sub-terms | 1 |
| 57 | were172 | 1 |
| 58 | wereas | 1 |
| 59 | werr | 1 |
| 60 | wthe | 1 |
| 61 | €5 | 1 |
| 1 | -0123/rtog | 1 |
| 2 | -3-oxopropanal | 1 |
| 3 | -conformed | 1 |
| 4 | -f264y | 1 |
| 5 | -half | 1 |
| 6 | -hexa-2-en-4-ynoates | 1 |
| 7 | -hexapeptides | 1 |
| 8 | -kqlr-amc | 1 |
| 9 | -mean | 3 |
| 10 | -was | 9 |
| 11 | -were | 39 |
| 12 | -when | 3 |
| 13 | -yield | 1 |
| 14 | .anova | 1 |
| 15 | .valued | 1 |
| 16 | .were | 2 |
| 17 | .zdv | 4 |
| 18 | /telmisartan | 1 |
| 19 | 9343 | 1 |
| 20 | anthracycline-cyclophosphamide | 1 |
| 21 | bacteremia.we | 1 |
| 22 | bodyweight-cut-point | 1 |
| 23 | c*3 | 1 |
| 24 | ce.6/26062/22061 | 1 |
| 25 | died/were | 1 |
| 26 | events.four | 1 |
| 27 | exenatide-failures | 2 |
| 28 | fatigue/vigor | 1 |
| 29 | fpsa.we | 1 |
| 30 | freelight-2 | 1 |
| 31 | g300104 | 1 |
| 32 | hypnotically | 1 |
| 33 | image-galleries | 1 |
| 34 | inattentiveness-were | 1 |
| 35 | leakage- | 1 |
| 36 | maternalcomplicationswere | 1 |
| 37 | mg/dl-was | 1 |
| 38 | mm6 | 1 |
| 39 | models-the | 2 |
| 40 | nscaw-1 | 1 |
| 41 | open-was | 1 |
| 42 | participants.screening | 1 |
| 43 | potencially | 1 |
| 44 | pweight-bearing*8685not | 1 |
| 45 | ratner | 1 |
| 46 | revalor-is | 1 |
| 47 | ring-slippage | 1 |
| 48 | se-i | 1 |
| 49 | severity-was | 1 |
| 50 | shengwei | 1 |
| 51 | sub-terms | 1 |
| 52 | wee | 8 |
| 53 | wer | 8 |
| 54 | werde | 2 |
| 55 | were | 863,432 |
| 56 | were172 | 1 |
| 57 | wereas | 1 |
| 58 | werr | 1 |
| 59 | wthe | 1 |
| 60 | zr-hopo | 3 |
| 61 | €5 | 1 |
| 1 | leakage- | 1 |
| 2 | nscaw-1 | 1 |
| 3 | ce.6/26062/22061 | 1 |
| 4 | freelight-2 | 1 |
| 5 | were172 | 1 |
| 6 | c*3 | 1 |
| 7 | 9343 | 1 |
| 8 | g300104 | 1 |
| 9 | €5 | 1 |
| 10 | mm6 | 1 |
| 11 | .anova | 1 |
| 12 | -kqlr-amc | 1 |
| 13 | -conformed | 1 |
| 14 | .valued | 1 |
| 15 | -yield | 1 |
| 16 | anthracycline-cyclophosphamide | 1 |
| 17 | werde | 2 |
| 18 | wee | 8 |
| 19 | ring-slippage | 1 |
| 20 | models-the | 2 |
| 21 | wthe | 1 |
| 22 | were | 863,432 |
| 23 | -were | 39 |
| 24 | inattentiveness-were | 1 |
| 25 | .were | 2 |
| 26 | died/were | 1 |
| 27 | maternalcomplicationswere | 1 |
| 28 | bacteremia.we | 1 |
| 29 | fpsa.we | 1 |
| 30 | -half | 1 |
| 31 | participants.screening | 1 |
| 32 | -0123/rtog | 1 |
| 33 | se-i | 1 |
| 34 | shengwei | 1 |
| 35 | -3-oxopropanal | 1 |
| 36 | -mean | 3 |
| 37 | /telmisartan | 1 |
| 38 | -when | 3 |
| 39 | zr-hopo | 3 |
| 40 | ratner | 1 |
| 41 | wer | 8 |
| 42 | fatigue/vigor | 1 |
| 43 | werr | 1 |
| 44 | events.four | 1 |
| 45 | wereas | 1 |
| 46 | -was | 9 |
| 47 | mg/dl-was | 1 |
| 48 | open-was | 1 |
| 49 | severity-was | 1 |
| 50 | -hexapeptides | 1 |
| 51 | image-galleries | 1 |
| 52 | exenatide-failures | 2 |
| 53 | -hexa-2-en-4-ynoates | 1 |
| 54 | revalor-is | 1 |
| 55 | sub-terms | 1 |
| 56 | bodyweight-cut-point | 1 |
| 57 | pweight-bearing*8685not | 1 |
| 58 | .zdv | 4 |
| 59 | -f264y | 1 |
| 60 | hypnotically | 1 |
| 61 | potencially | 1 |